Cargando…

Validation and implementation of the Panbio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers

BACKGROUND: RT-PCR is the current recommended laboratory method to diagnose SARS-CoV-2 in healthcare workers (HCW). As RT-PCR is not widely available and is time-consuming, it limits decision making on removal from and return to work of possibly contagious HCW. AIM: In this study we evaluated the Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolwijck, E., Brouwers-Boers, M., Broertjes, J., van Heeswijk, K., Runderkamp, N., Meijer, A., Hermans, M.H.A., Leenders, A.C.A.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050397/ https://www.ncbi.nlm.nih.gov/pubmed/34316580 http://dx.doi.org/10.1016/j.infpip.2021.100142

Ejemplares similares

Evaluation of the Abbott Panbio(™) COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
por: Eikelenboom-Boskamp, Andrea, et al.
Publicado: (2023)

Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres
por: Albert, Eliseo, et al.
Publicado: (2021)

Evaluation of the Panbio™ COVID-19 ag rapid test at an emergency room in a hospital in São Paulo, Brazil
por: Faíco-Filho, Klinger Soares, et al.
Publicado: (2022)

Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study
por: Thirion-Romero, Ireri, et al.
Publicado: (2021)

Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care
por: Bulilete, Oana, et al.
Publicado: (2021)

COVID‐19 in Morocco's region: Observational study of prevalence in symptomatic adults using the PANBIOS® rapid antigen test September 2021
por: Haroun, Abbas Ermilo, et al.
Publicado: (2023)

Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
por: Castineiras, Terezinha Marta Pereira Pinto, et al.
Publicado: (2021)

Evaluation of the Abbott Panbio(TM) COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians
por: Shaw, Julie L V, et al.
Publicado: (2021)

Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection
por: Oh, Sang-Min, et al.
Publicado: (2022)

Low sensitivity of the COVID-19 antigen test (PANBIO™ COVID-19 Ag rapid test) to detect asymptomatic infections in health personnel of the National Institute of Respiratory Diseases
por: Becerril Vargas, Eduardo, et al.
Publicado: (2022)

Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test
por: Alemany, Andrea, et al.
Publicado: (2021)

Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
por: Ngo Nsoga, Marie Thérèse, et al.
Publicado: (2021)

Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients
por: Torres, Ignacio, et al.
Publicado: (2021)

Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population
por: Gallardo-Alfaro, Laura, et al.
Publicado: (2023)

Experience with Panbio™ rapid antigens test device for the detection of SARS-CoV-2 in nursing homes()
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19
por: Fenollar, Florence, et al.
Publicado: (2021)

Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age
por: Masiá, Mar, et al.
Publicado: (2021)

Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023)

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study
por: Agulló, Vanesa, et al.
Publicado: (2021)

Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens
por: Galliez, Rafael Mello, et al.
Publicado: (2022)

Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection
por: Pérez-García, Felipe, et al.
Publicado: (2021)

Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection
por: Merino, Paloma, et al.
Publicado: (2021)

Evaluación de la prueba diagnóstica de detección rápida de antígeno de covid-19 (Panbio Covid rapid test) en atención primaria
por: Cortés Rubio, J.A., et al.
Publicado: (2021)

Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation
por: Irungu, Jack Karuga, et al.
Publicado: (2023)

Comparison of Performance of Serum and Plasma in Panbio Dengue and Japanese Encephalitis Virus Enzyme-Linked Immunosorbent Assays
por: Blacksell, Stuart D., et al.
Publicado: (2012)

Evaluation of the Panbio Leptospira IgM ELISA among Outpatients Attending Primary Care in Southeast Asia
por: Dhawan, Sandhya, et al.
Publicado: (2021)

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
por: Linares, Manuel, et al.
Publicado: (2020)

Misdiagnosis rate among negative COVID-19 patients in real-life with Panbio COVID-19 antigen rapid test during 2021
por: Ryan, Pablo, et al.
Publicado: (2022)

Evaluation of the performance of Panbio™ COVID-19 antigen rapid diagnostic test for the detection of SARS-CoV-2 in suspected patients in Ethiopia
por: Dessalegn, Dejene, et al.
Publicado: (2022)

Laboratory and field evaluation of the STANDARD Q and Panbio(™) SARS-CoV-2 antigen rapid test in Namibia using nasopharyngeal samples
por: Konstantinus, Iyaloo, et al.
Publicado: (2022)

Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
por: Gremmels, Hendrik, et al.
Publicado: (2020)

Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November 15 and December 10, 2021 Using a Single Lateral Flow Test, the Panbio™ COVID-19 Ag Rapid Test
por: Gujski, Mariusz, et al.
Publicado: (2022)

Synthesis and Application of Silver Nanoparticles (Ag NPs) for the Prevention of Infection in Healthcare Workers
por: Nakamura, Shingo, et al.
Publicado: (2019)

Diagnostic accuracy of SARS-CoV-2 Panbio™ rapid antigen diagnostic tests in a 4,440-case clinical follow-up
por: Hamar, Ágoston, et al.
Publicado: (2022)

Prevalence of Coronavirus Disease 2019 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington
por: Mani, Nandita S, et al.
Publicado: (2020)

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
por: Krüger, Lisa J., et al.
Publicado: (2021)

Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk
por: Murillo-Zamora, Efrén, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
por: Nunes, Marta C., et al.
Publicado: (2022)

Evaluation of the performance of Abbott Panbio™ COVID-19 antigen rapid diagnostic test for the detection of severe acute respiratory syndrome coronavirus 2 at Harar, Eastern Ethiopia
por: Teklemariam, Zelalem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g2m5g6hgt7l4ub6dvsn8t2goq8